Group One Trading’s Apollo Endosurgery, Inc. APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-360
Closed -$3.57K 8240
2022
Q4
$3.59K Buy
+360
New +$2.68K ﹤0.01% 6470
2016
Q1
Sell
-16
Closed 5085
2015
Q4
$0 Sell
16
-119
-88% -$2K ﹤0.01% 5206
2015
Q3
$2K Sell
135
-111
-45% -$2.12K ﹤0.01% 4701
2015
Q2
$5K Buy
246
+93
+61% +$9.2K ﹤0.01% 4514
2015
Q1
$29K Buy
153
+150
+5,000% +$34.5K ﹤0.01% 3702
2014
Q4
$1K Sell
3
-22
-88% -$4.91K ﹤0.01% 4797
2014
Q3
$7K Hold
25
﹤0.01% 4628
2014
Q2
$8K Sell
25
-23
-48% -$7.3K ﹤0.01% 4610
2014
Q1
$18K Buy
48
+38
+380% +$13.8K ﹤0.01% 4313
2013
Q4
$3K Buy
10
+9
+900% +$3.31K ﹤0.01% 4994
2013
Q3
$1K Buy
+1
New +$438 ﹤0.01% 5046

Group One Trading's APEN Position: Q1 2023 in Review

Group One Trading sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2023, closing a stake of 360 shares — an estimated $3.57K sold.

Group One Trading first reported a position in APEN in Q3 2013 and held it in 11 quarters. The position peaked at $29K in Q1 2015. 89 funds tracked by Wall St. Rank hold APEN as of Q1 2023.

  • Group One Trading reported no remaining Apollo Endosurgery, Inc. position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 360 Apollo Endosurgery, Inc. shares in Q1 2023, an estimated $3.57K.
  • Group One Trading first reported a position in Apollo Endosurgery, Inc. in Q3 2013 and held it in 11 quarters.
  • Group One Trading's Apollo Endosurgery, Inc. position peaked at $29K in Q1 2015.
  • 89 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.